No Data
No Data
J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
We Think Hanesbrands (NYSE:HBI) Is Taking Some Risk With Its Debt
Express News | HanesBrands Shares Rise 4.5% Premarket
This Eastman Chemical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
UBS Upgrades Hanesbrands to Buy, Raises Price Target to $11
UBS Upgrades Hanesbrands(HBI.US) to Buy Rating, Raises Target Price to $11
No Data
No Data